Teva seeks to hide Israel ties in price-fixing trial

Sun Pharma has filed a motion in U.S. federal court in Philadelphia to prevent insurer Humana from telling jurors that Teva is an Israeli company during an upcoming drug price-fixing trial. Teva argues that strong public sentiment over the Gaza war could prejudice the jury and deny it a fair hearing. The trial, part of a long-running antitrust case, is scheduled to begin September 15 and end by late October. Teva denies allegations that it conspired with other drug makers to inflate generic drug prices. Humana has filed a counter-motion to bar the drug companies from introducing inflammatory evidence about health insurers, citing the 2024 killing of UnitedHealth Group executive Brian Thompson. The case highlights the intersection of geopolitical tensions and corporate litigation in the U.S.